NewAmsterdam Pharma Company N.V. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 16.70 M | $475.00 M | 0.57% | 14.84% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2025 | 10.72 M | $304.85 M | 0.00% | 9.53% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 10.14 M | $288.35 M | 0.00% | 9.01% |
| CAPITAL WORLD INVESTORS | 11/13/2025 | 9.82 M | $279.36 M | 17.11% | 8.73% |
| FCPM III SERVICES B.V. | 11/14/2025 | 9.21 M | $262.00 M | -13.35% | 8.19% |
| VIKING GLOBAL INVESTORS LP | 11/14/2025 | 6.48 M | $184.16 M | -7.21% | 5.76% |
| FMR LLC | 11/13/2025 | 5.54 M | $157.42 M | 190.64% | 4.92% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 4.27 M | $121.34 M | -16.60% | 3.79% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 4.20 M | $119.41 M | 42.51% | 3.73% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 4.02 M | $114.33 M | 20.98% | 3.57% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 2.91 M | $82.81 M | 15.64% | 2.59% |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 10/17/2025 | 2.87 M | $81.61 M | 0.00% | 2.55% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 2.58 M | $73.28 M | -14.48% | 2.29% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 2.18 M | $61.86 M | 0.00% | 1.93% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 2.14 M | $60.91 M | -8.14% | 1.90% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 2.12 M | $60.15 M | 7.90% | 1.88% |
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2025 | 2.06 M | $58.66 M | 0.00% | 1.83% |
| DUQUESNE FAMILY OFFICE LLC | 11/14/2025 | 1.92 M | $54.71 M | 131.17% | 1.71% |
| MAVERICK CAPITAL LTD | 11/14/2025 | 1.50 M | $42.80 M | -1.77% | 1.34% |
| MORGAN STANLEY | 11/14/2025 | 1.50 M | $42.59 M | 134.82% | 1.33% |
| JPMORGAN CHASE & CO | 11/26/2025 | 1.30 M | $37.04 M | -10.72% | 1.16% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.29 M | $36.75 M | -28.87% | 1.15% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 1.17 M | $33.27 M | 3,799.00% | 1.04% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.16 M | $32.93 M | -38.97% | 1.03% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 1.00 M | $28.44 M | 100.00% | 0.89% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 880.55 K | $25.04 M | -7.31% | 0.78% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 11/07/2025 | 837.37 K | $23.81 M | -4.03% | 0.74% |
| UBS GROUP AG | 11/13/2025 | 768.52 K | $21.86 M | 22.43% | 0.68% |
| SIREN, L.L.C. | 11/13/2025 | 765.71 K | $21.78 M | -35.88% | 0.68% |
| FIRST TURN MANAGEMENT, LLC | 11/14/2025 | 716.97 K | $20.39 M | 37.59% | 0.64% |
| ABRDN PLC | 11/07/2025 | 661.95 K | $18.83 M | -9.94% | 0.59% |
| DECHENG CAPITAL LLC | 11/14/2025 | 657.05 K | $18.69 M | -14.67% | 0.58% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 624.29 K | $17.75 M | 17.15% | 0.55% |
| BLACKROCK, INC. | 11/12/2025 | 622.52 K | $17.70 M | 8.89% | 0.55% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 595.93 K | $16.95 M | 11.16% | 0.53% |
| EVERSEPT PARTNERS, LP | 11/14/2025 | 488.59 K | $13.90 M | 17.89% | 0.43% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 472.10 K | $13.43 M | -2.46% | 0.42% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 405.83 K | $11.54 M | 21.43% | 0.36% |
| HANDELSBANKEN FONDER AB | 11/12/2025 | 405.80 K | $11.54 M | 18.79% | 0.36% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 333.00 K | $9.47 M | -5.65% | 0.30% |
| SLATE PATH CAPITAL LP | 11/14/2025 | 319.00 K | $9.07 M | 0.00% | 0.28% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2025 | 311.00 K | $8.84 M | -13.28% | 0.28% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 275.00 K | $7.82 M | 0.00% | 0.24% |
| CITADEL ADVISORS LLC | 11/14/2025 | 206.46 K | $5.87 M | -35.51% | 0.18% |
| AXA INVESTMENT MANAGERS S.A. | 11/14/2025 | 196.78 K | $5.60 M | 100.00% | 0.17% |
| ARTIA GLOBAL PARTNERS LP | 11/14/2025 | 194.84 K | $5.54 M | 613.20% | 0.17% |
| HEALTHINVEST PARTNERS AB | 11/04/2025 | 193.63 K | $584.61 K | 23.15% | 0.17% |
| NICHOLAS INVESTMENT PARTNERS, LP | 11/14/2025 | 177.54 K | $5.05 M | 53.40% | 0.16% |
| DCF ADVISERS, LLC | 11/12/2025 | 175.25 K | $4.98 M | 1.59% | 0.16% |
| VANGUARD GROUP INC | 11/07/2025 | 172.47 K | $4.90 M | -3.57% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NewAmsterdam Pharma Company N.V. institutional Ownership - FAQ's
During the previous two years, 156 institutional investors and hedge funds held shares of NewAmsterdam Pharma Company N.V.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 16.7 M
Bain Capital Life Sciences Investors, LLC: 10.72 M
RA CAPITAL MANAGEMENT, L.P.: 10.14 M
Capital World Investors: 9.82 M
FCPM III SERVICES B.V.: 9.21 M
VIKING GLOBAL INVESTORS LP: 6.48 M
107.20% of NewAmsterdam Pharma Company N.V. stock is owned by institutional investors.
Institutional investors have bought a total of 120.85 M shares in the last 24 months. This purchase volume represents approximately $3.71 B in transactions.